Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium.

Autor: Balgobind BV; Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands. Electronic address: b.v.balgobind@amsterdamumc.nl., Visser J; Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Grehn M; Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Marquard Knap M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., de Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University, Maastricht, the Netherlands., Levis M; Department of Oncology, University of Torino, Torino, Italy., Alcantara P; Department of Radiation Oncology, Hospital Clínico San Carlos, Faculty of Medicine, University Complutense of Madrid, Madrid, Spain., Boda-Heggemann J; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Both M; Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein, Kiel, Germany., Cozzi S; Radiation Oncology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy; Radiation Oncology Department, Centre Léon Bérard, Lyon, France., Cvek J; Department of Oncology, University Hospital and Faculty of Medicine, Ostrava, Czech Republic., Dieleman EMT; Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Elicin O; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Giaj-Levra N; Department of Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy., Jumeau R; Department of Radio-Oncology, Lausanne University Hospital, Lausanne, Switzerland., Krug D; Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Algara López M; Department of Radiotherapy, Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain., Mayinger M; Department of Radiation Oncology, University Hospital of Zurich, Zurich, Switzerland., Mehrhof F; Department for Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Miszczyk M; IIIrd Radiotherapy and Chemotherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Pérez-Calatayud MJ; Department of Radiation Oncology, Hospital General Valencia, Valencia, Spain., van der Pol LHG; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands., van der Toorn PP; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., Vitolo V; Radiation Oncology Clinical Department, National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy., Postema PG; Department of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Pruvot E; Heart and Vessel Department, Service of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Verhoeff JC; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands., Blanck O; Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Dec; Vol. 189, pp. 109949. Date of Electronic Publication: 2023 Oct 10.

Radiotherapy for Ledderhose disease: Results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial.

Autor: de Haan A; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, the Netherlands. Electronic address: a.de.haan01@umcg.nl., van Nes JGH; Radiotherapeutisch Instituut Friesland, Leeuwarden, the Netherlands., Kolff MW; Amsterdam University Medical Center, Department of Radiation Oncology, Amsterdam, the Netherlands., van der Toorn PP; Catharina Hospital Eindhoven, Department of Radiation Oncology, the Netherlands., Westenberg AH; Radiotherapiegroep Arnhem, Ede, the Netherlands., van der Vegt AE; University of Groningen, University Medical Center Groningen, Department of Rehabilitation Medicine, Groningen, the Netherlands., Groen H; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands., Overbosch J; University of Groningen, University Medical Center Groningen, Department of Radiology, Groningen, the Netherlands., van der Laan HP; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, the Netherlands., Werker PMN; University of Groningen, University Medical Center Groningen, Department of Plastic Surgery, Groningen, the Netherlands., Langendijk JA; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, the Netherlands., Steenbakkers RJHM; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, the Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Aug; Vol. 185, pp. 109718. Date of Electronic Publication: 2023 May 20.

Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trial.

Autor: Hartgerink D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Bruynzeel A; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Eekers D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Swinnen A; Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Hurkmans C; Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands., Wiggenraad R; Department of Radiation Oncology, Haaglanden Medical Center, The Hague, The Netherlands., Swaak-Kragten A; Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands., Dieleman E; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., van der Toorn PP; Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands., van Veelen L; Department of Radiation Oncology, Zuid-West Radiotherapy Institute, Vlissingen, The Netherlands., Verhoeff JJC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Lagerwaard F; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., de Ruysscher D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Lambin P; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, The Netherlands., Zindler J; Department of Radiation Oncology, Haaglanden Medical Center, The Hague, The Netherlands; Department of Radiotherapy, Holland Proton Therapy Center, Delft, The Netherlands.

Publikováno v: Annals of palliative medicine [Ann Palliat Med] 2022 Apr; Vol. 11 (4), pp. 1197-1209. Date of Electronic Publication: 2021 Nov 18.

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases.

Autor: Hartgerink D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Bruynzeel A; Department of Radiation Oncology, Amsterdam University Medical Centers, the Netherlands., Eekers D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Swinnen A; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Hurkmans C; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., Wiggenraad R; Department of Radiation Oncology, Haaglanden Medical Center, the Netherlands., Swaak-Kragten A; Department of Radiation Oncology, Erasmus MC, Rotterdam, the Netherlands., Dieleman E; Department of Radiation Oncology, Amsterdam University Medical Centers, the Netherlands., van der Toorn PP; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., Oei B; Department of Radiation Oncology, Verbeeten Institute Tilburg, the Netherlands., van Veelen L; Department of Radiation Oncology, Zuid-West Radiotherapy Institute Vlissingen, the Netherlands., Verhoeff J; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Lagerwaard F; Department of Radiation Oncology, Amsterdam University Medical Centers, the Netherlands., de Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Lambin P; Department of Precision Medicine, The M-Lab, GROW - School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University, Maastricht, the Netherlands., Zindler J; Department of Radiation Oncology, Haaglanden MC, Den Haag, the Netherlands.; Holland Proton Therapy Center, Delft, the Netherlands.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2021 Feb 01; Vol. 3 (1), pp. vdab021. Date of Electronic Publication: 2021 Feb 01 (Print Publication: 2021).

Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.

Autor: Zindler JD; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands. Electronic address: jaap.zindler@maastro.nl., Jochems A; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., Lagerwaard FJ; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands., Beumer R; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., Troost EGC; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands; Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf, Germany., Eekers DBP; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., Compter I; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., van der Toorn PP; Department of Radiation Oncology, Catharina Hospital Eindhoven, The Netherlands., Essers M; Department of Radiation Oncology, Verbeeten Institute, Tilburg, The Netherlands., Oei B; Department of Radiation Oncology, Verbeeten Institute, Tilburg, The Netherlands., Hurkmans CW; Department of Radiation Oncology, Catharina Hospital Eindhoven, The Netherlands., Bruynzeel AME; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands., Bosmans G; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., Swinnen A; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., Leijenaar RTH; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., Lambin P; Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 May; Vol. 123 (2), pp. 189-194. Date of Electronic Publication: 2017 Feb 23.